AI-driven drug discovery platform developing RNA-targeting molecular glues to enable transcriptional modulation for oncology and neuromuscular diseases with high unmet need. Scalable, tech-enabled discovery engine advancing a diversified preclinical pipeline toward proof-of-concept.